Inventor
Hans-Georg Lerchen
Inventor
Leverkusen, DE
Overview
Patents· 40 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes25%
C07DHeterocyclic compounds21%
C07KPeptides19%
C07CAcyclic or carbocyclic compounds3%
C07HSugars2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
11,123,439Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups202111,071,788Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies202111,001,636Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies202110,973,923Site specific homogeneous with KSP inhibitors202110,744,205Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies202010,485,880Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies201910,350,206Benzyl substituted indazoles as BUB1 inhibitors201910,035,818Polyethylene glycol based prodrug of adrenomedullin and use thereof201810,022,453Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)20189,649,363'Polyethylene glycol based prodrug of adrenomedullin and use thereof'20179,603,936'Polyethylene glycol based prodrug of adrenomedullin and use thereof'20179,586,958'Prodrug derivatives of substituted triazolopyridines'20179,315,543'Tyrosine based linkers for the releasable connection of peptides'20169,040,566'Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension'20159,029,406'N-carboxyalkylauristatins and use thereof'20158,992,932'Binder-drug conjugates (ADCs) and use thereof'20158,987,209'N-carboxyalkyl-auristatin and the use thereof'20158,957,017'Dipeptoid prodrugs and their use'20158,772,498'Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof'20148,741,834'Dipeptoid prodrugs and the use thereof'20148,722,629'Auristatin derivatives and use thereof'20148,703,696'Dipeptoid prodrugs and the use thereof'20148,420,825'Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs'20138,362,015'Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders'20138,334,284'Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders'20128,101,601'Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders'20127,304,037'Cytostatic conjugates with integrin ligands'20077,220,824'Integrin-mediated drug targeting'20077,132,295'Isotopically coded affinity markers 3'20066,649,647'Trioxane derivatives'20036,506,734'20(S) camptothecin glycoconjugates'20036,492,335'Glycoconjugates from modified camptothecin derivatives (20-O-linkage)'20026,468,966'Octacyclodepsipeptides having an endoparasiticidal action'20026,369,028'Octacyclodepsipeptides having an endoparasiticidal action'20026,271,342'Sugar-modified cytostatics'20016,156,754'Glycoconjugates of modified camptothecin derivatives (A-or B-ring linkage)'20005,874,438'2,2\'-bridged bis-2,4-diaminoquinazolines'19995,777,075'Octacyclodepsipeptides having an endoparasiticidal action'19985,760,230'4, 4\'-bridged bis-2, 4-diaminoquinazolines'19985,717,063'Octacyclodepsipeptides having an endoparasiticidal action'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2007Patents assigned to BAYER AG (13)· patent assignee history
1998–1999Based in Koln, DE· patent location history
2000–2021Based in Leverkusen, DE· patent location history
2002Based in Kln, DE· patent location history
2012–2021Patents assigned to Bayer Pharma AG (14)· patent assignee history
2012–2018Patents assigned to BAYER IP GMBH (12)· patent assignee history
2012–2015Patents assigned to LERCHEN HANS-GEORG (10)· patent assignee history
2012–2015Patents assigned to KRENZ URSULA (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| Bayer Pharma AG | 14 | 2012–2021 |
| BAYER AG | 13 | 1998–2007 |
| BAYER IP GMBH | 12 | 2012–2018 |
| LERCHEN HANS-GEORGself | 10 | 2012–2015 |
| KRENZ URSULA | 8 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Leverkusen, DE | 34 | 2000–2021 |
| Koln, DE | 4 | 1998–1999 |
| Kln, DE | 2 | 2002 |